Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1091220264Completed
Open-label trial in dengue fever (2 arms), sponsored by Sumitomo Chemical. Primary endpoint: IgG seropositivity ratio. Started Nov 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1091220264.